Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: VIXandMore who wrote (9948)	1/7/2004 11:46:19 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 52153

I've watched it with curiosity, as the CEO is an acquaintance from the way back days at UCLA and I'm interested in companies that look at pathologic protein folding/aggregation. Sort of a closed shop..... Board is composed of lotsa self-interest. Ferris has been around for a long time and has looked at many molecules in human clinical trials. I've been afraid to touch it..... don't have enough experience beyond the basics of cholinesterase inhibition, which isn't the sexy part of phenserine. There seems to be publications and additional documentation out there for everything they say. It's exciting. I just can't get a handle, and the cholinesterase inhibitor turned magic Abeta inhibitor just seems to good to be true. Could be a great flyer, scares the bejeezus out of me.